CellCept 250 Roche
Generic Name: mycophenolate mofetil
Pill imprint CellCept 250 Roche has been identified as Cellcept 250 mg.
CellCept is used in the treatment of organ transplant, rejection prophylaxis; nephrotic syndrome; inflammatory bowel disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy.
CellCept 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Cellcept Images
- Generic Name:
- mycophenolate mofetil
- Imprint:
-
CellCept 250
Roche - Strength:
- 250 mg
- Color:
- Orange & Turquoise
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
magnesium stearate
povidone k90
corn starch
ferrosoferric oxide
FD&C Blue No. 2
gelatin
ferric oxide yellow
ferric oxide red
titanium dioxide
silicon dioxide
sodium lauryl sulfate
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-0259
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68258-9073 | Dispensing Solutions Inc. (repackager) |
| 21695-0171 | Rebel Distributors Corp (repackager) |
| 49999-0936 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More CellCept resources
- Cellcept
- CellCept (Wolters Kluwer)
- CellCept Capsules (Wolters Kluwer)
- CellCept Solution (Wolters Kluwer)
- CellCept Suspension (Wolters Kluwer)
- CellCept (Cerner Multum)
- Cellcept (Micromedex) - Includes Dosage Information
- Cellcept Oral (Micromedex) - Includes Dosage Information
- CellCept (FDA)
Search Again
